Document is current
Any future updates will be listed below
-
Authors
Tao, Changcheng
Yang, Huiru
Hu, Nan
Zheng, Bo
Lu, Zhiyu
Rong, Weiqi
Wu, Fan
Wang, Liming
Cao, Dayong
Wu, Jianxiong
Tu, Zhanhan
Meng, Xuan
Lu, Haizhen
Wang, Hongguang
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2400082814 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Innovative rapid pathological assessment technology for hepatocellular carcinoma following comprehensive treatment guided by indocyanine green fluorescence imaging
https://doi.org/10.1007/s13304-025-02301-2
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272963)
Natural Science Foundation of Beijing Municipality (4222058)
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 13 June 2025
First Online: 7 July 2025
Declarations
:
: The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
: This study had been approved by the Ethics Committee. According to the Declaration of Helsinki, all participants were willing to participate in this study and gave their informed consent.
: All authors who contributed to the study agree to publish it.
